Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA. Akhondzadeh S, et al. Among authors: rezazadeh sa. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1879-83. doi: 10.1016/j.pnpbp.2008.08.020. Epub 2008 Sep 4. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18801405 Clinical Trial.
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S. Akhondzadeh S, et al. Among authors: rezazadeh sa. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):32-6. doi: 10.1016/j.pnpbp.2009.09.012. Epub 2009 Sep 20. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19772883 Clinical Trial.
Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S. Salehi B, et al. Among authors: rezazadeh sa. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76-80. doi: 10.1016/j.pnpbp.2009.09.026. Epub 2009 Oct 5. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19815048 Clinical Trial.
A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.
Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A. Akhondzadeh S, et al. Among authors: rezazadeh sa. Psychopharmacology (Berl). 2010 Jan;207(4):637-43. doi: 10.1007/s00213-009-1706-1. Epub 2009 Oct 20. Psychopharmacology (Berl). 2010. PMID: 19838862 Clinical Trial.
Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.
Akhondzadeh S, Ghayyoumi R, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Tabrizi M, Rezazadeh SA. Akhondzadeh S, et al. Among authors: rezazadeh sa. Psychopharmacology (Berl). 2011 Feb;213(4):809-15. doi: 10.1007/s00213-010-2044-z. Epub 2010 Oct 15. Psychopharmacology (Berl). 2011. PMID: 20949350 Clinical Trial.
25 results